Partnership Opportunities
As rare and genetic kidney disease drug development accelerates with recent approvals and increased investment, companies are navigating increasingly complex clinical, regulatory, and translational challenges. From validating surrogate endpoints and improving trial feasibility to recruiting patients across small and geographically dispersed populations, the need for specialist partners has never been greater.
Organizations are actively seeking partners who can improve trial feasibility, de-risk development, and drive stronger clinical and commercial outcomes. As a result, demand is growing for specialist service providers with the expertise to deliver impact across the development lifecycle, from executing complex clinical trials and building translationally relevant preclinical models to advancing novel targets, imaging approaches, and biomarker strategies.
The 6th Rare & Genetic Kidney Disease Drug Development Summit provides a focused platform for solution and service providers to engage directly with senior decision‑makers across pharma and biotech who are actively advancing renal pipelines. Attendees include leaders in Clinical Development, Translational Medicine, Regulatory Affairs, and Business Development, all seeking partners who can support progress across the full development spectrum.
Partnering positions your organization alongside the companies shaping the next generation of kidney disease therapies, enabling meaningful conversations, targeted visibility, and long‑term commercial engagement.
What to Expect?
Position Your Brand at the Centre of Renal Innovation
Increase your visibility across the rare kidney disease community through thought-leadership opportunities, on-site branding, and pre-event marketing. Ensure your organization is front-of-mind for companies seeking partners to accelerate their development strategies.
Gain Actionable Market Insight & Competitive Intelligence
Stay ahead of emerging trends by hearing directly from KOLs and industry leaders. Understand how companies are approaching biomarker validation, regulatory alignment, and trial design to refine your strategy and strengthen your market positioning.
Build High-Value Partnerships with Decision-Makers
Connect with senior leaders across biopharma and academia, including Clinical Development Directors, Translational Medicine Leads, Regulatory Affairs experts, and Business Development leaders, who are actively advancing rare kidney disease pipelines. Through curated networking sessions and interactive discussions, develop meaningful relationships that translate into long-term collaborations and new business opportunities.
Key Services & Solutions
Hear What Our Past Sponsors Have to Say
Great networking opportunities, pertinent content, and good conference flow. Will attend again.
Analyst, Searchlight Science
The 5th Rare & Genetic Kidney Disease Drug Development Summit was well organised, with great speakers
Epidemiologist Research Analyst, HealthLumen
The opportunity to network with peers, combined with the quality and relevance of the presentation content, made this a highly valuable experience
Business Development & Organ Health Professional, Natera
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.